| Ticker | ARKG (ARK Genomic Revolution ETF) |
|---|---|
| ARKG Price | $27.9 |
| Portfolio Manager | Catherine D. Wood |
| Top Holdings | EXACT SCIENCES CORP, TELADOC HEALTH INC, IONIS PHARMACEUTICALS INC |
| Top Sector | Health Care & Info Tech |
| Expense Ratio | 0.75% |
| Return Since Inception | 168.70% |
ARKG Holding is an actively managed exchange-traded fund seeking long-term growth by predominantly investing in genetics research and technology (at least 80% of its assets) in U.S. and foreign companies.
The fund invests in multiple sectors, including health care, information technology, materials, energy, and consumer discretionary.
ARKG ETF Price Chart
| Stock | Price | Change | Change % | Volume | 52 Week Range |
|---|---|---|---|---|---|
 ARK Genomic Revolution ETF ARKG | $27.6 | $0.31 | 1.11% | 1,378,204 |
ARKG is focused on enhancing the quality of human life by developing innovative solutions that build upon scientific advancements in genomics. By utilizing its unique business model, ARKG can provide its investors with access to a diverse portfolio of companies at a reduced cost.
Similar ARK ETFs List –
ARKQ, ARKW, ARKF, ARKK, ARKX, PRNT, and IZRL.
ARKG Stock Holdings (Updated)
(Download The Latest List Below – Updated Daily)
ARKG Annual Performance
| ARKG | NAV | Market Price |
| 2022 | -53.94% | -53.90% |
| 2021 | -33.89% | -33.92% |
| 2020 | 180.50% | 180.56% |
| 2019 | 43.78% | 44.06% |
| 2018 | 0.58% | 0.11% |
| 2017 | 45.39% | 46.60% |
Important Note: Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
Total Return reflects the reinvestment of distributions on ex-date for NAV returns and payment date for Market Price returns. The market price of the ETF’s shares may differ significantly from their NAV during periods of market volatility.
Exposure Breakdowns
Here are the few charts that explain where is ETF Holding…
1 TECHNOLOGY BREAKDOWN
2 MARKET CAPITALIZATION
3 SECTOR BREAKDOWN
ARKK vs ARKG
| Issuer ARK | ARKG | ARKK |
| ETF Database Category | Health & Biotech Equities | All Cap Equities |
| Expense Ratio | 0.75% | 0.75% |
| Inception Date | 2014-10-31 | 2014-10-31 |
| AUM | $3.8B | $11.8B |
| Shares Outstanding | 83.2M | 170M |
Market Price Return In the last 5 Years –
Should You Invest In ARKG?
ARK-G ETF focused on health care, information technology, materials, energy, and consumer discretionary sectors. Based on the report, if you invest $10,000 in this ETF fund, you’ll get better returns than the S&P 500 Returns.
Frequently Asked Questions
Q. What are the top holdings of the ARKG Fund?
| EXACT SCIENCES CORP |
| TELADOC HEALTH INC |
| IONIS PHARMACEUTICALS INC |
| FATE THERAPEUTICS INC |
| SIGNIFY HEALTH INC -CLASS A |
| VERTEX PHARMACEUTICALS INC |
| CRISPR THERAPEUTICS AG |
| BEAM THERAPEUTICS INC |
| PACIFIC BIOSCIENCES OF CALIF |
| INTELLIA THERAPEUTICS INC |
Q. What are the charges?
The expense ratio is 0.75%
Q. Is ETF Fund is Risky?
If you come blindly, there is risk in the entire stock market. Taking about ARK, It’s like a mutual fund, which is managed by a team of experts and ensures that you get a better return on your investment. It also keeps looking for new opportunities, so sometimes an investor’s portfolio goes down due to market volatility. But long story short no doubt ETFs are a good investment in the long run.
Disclaimer ✋
The information included at this site is for educational purposes only and is not intended to be a substitute for investment advice. Data on past performance, where given, is not necessarily a guide to future performance. So before investing you should carefully consider the Fund’s investment objectives, risks, charges, and expenses.
0 Comments